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Introduction 
For successful human pancreatic islet transplantation 
it remains an elusive goal to solve the problems of 
quantity, purity, and viability (Hering, Bretzel and 
Federlin 1989). Thus, preparation of islets for trans-
plantation has required the development of a new 
field of biotechnology. 
One prerequisite for unimpaired islet graft function is 
the separation from the presumably cytotoxic and 
highly immunogenic exocrine tissue (Ulricks and 
MuUer-Ruchholtz: cf. page 123 in this book; Gray 
1989). Three different principles of islet purification 
are used: (A) "Hand-picking" is a method eSUlblished 
for purification of islets from the rodent pancreas 
(Finke, Lacy and Ono 1979). But for the high num-
ber of islets needed for human islet transplantation 
this method is too time-consuming and far too 
laborious. (B) Density gradient centrifugation is de-
pendent on the different densities of exocrine and 
endocrine tissue. Large scale purification by this 
method presently achieves purity degrees of approx. 
40%-70% (Lake, Bassett, Larkins, Revell, Walczak. 
Chamberlain. Rumford. London. Veitch. Bell and 
lames 1989; Ricordi. Lacy and Scharp 1989; War-
nock, Ellis. Cattral. Untch. Kneteman and Rajotte 
1989). This is partly explained by the difficulties to 
control the collagenase digestion process. (C) The 
principle of electromagnetic cell separation (EMS; 
Kandzia. Scholz. Anderson and Muller-Ruchholtz 
1984; Muller-Ruchholtz. Kandzia and Leyhausen 
1987) was further developed for large scale islet 
purification (Muller-Ruchholtz. Leyhausen. Petersen. 
Schubert and Ulricks 1987). Magnetic microspheres 
(MMS) were coupled to lectins with binding specif-
icity for exocrine tissue. UEA-I was found to be a 
highly selective lectin for rat (Muller-Ruchholtz et al. 
1987) and WFA for human (Winoto-Morbach. Ul-
ricks. Leyhausen and Muller-Ruchholtz 1989; 
Winoto-Morbach. Leyhausen. Schunke. Ulrichs and 
Muller-Ruchholtz 1989) exocrine tissue. Lectin-
coupled MMS can trap the latter in an electromag-
netic field, thus providing effluent islets of a high 
degree of purity. Functional integrity of EMS-sepa-
rated rat islets was tested in vivo (Muller-Ruchholtz 
et al. 1987) and in vitro (Winoto-Morbach et al. 
1989). 
Because of the difficulties to obtain sufficient human 
material we propose other species (cattle, pig and 
dog) to perform extensive preclinical studies and to 
collect data in view of the possibility of future islet 
xenotransplantation (Reemtsma 1989). This has the 
advantage of unlimited access to material for large 
scale islet separation. But for each new species used 
as islet donor, a particular lectin has to be found to 
make this approach effective for either experimental 
or clinical purposes. Therefore our interest was fo-
cussed on lectins with adequate specificity for pan-
creatic exocrine tissue of cattle, pig and dog. The 
characteristics of suitable lectins are the following: 
(a) high degree of binding specificity for the ade-
quate mammalian tissue, (b) non toxicity to endocrine 
cells, and (c) maintenance of binding specificity for 
exocrine cells after coupling to microspheres. 
Materials and Methods 
Islet preparation 
Animals of both sexes were used as donors, cattle at 
an average age of 12-18 months, weighing 400-500 
kg, pigs at an age of 6-8 months, weighing 80-100 
kg, and dogs, adult beagles, weighing 10-15 kg. The 
pancreata were intraductally distended with pre-
warmed 828-30 ·C) Hank's balanced salt solution 
(HBSS) containing 0.2% collagenase (Serva Heidel-
berg, Germany), 0.03% DNase type I grade II (Boeh-
ringer Mannheim, Germany) and 2% heat-inacti-
vated fetal calf serum (Gibco Eggenstein, Germany). 
The volume injected was 2 mVg pancreas sample. 
The digestion of the glands was performed in a con-
tinuous digestion-filtration device similar to the auto-
mated method developed by Ricordi. Lacy. Finke, 
Olack and Scharp (1988) and according to the 
method of Hering. Romann. Clarius. Brenzel. Slijep-
cevi. Bretzel and Federlin (1989). Crude islet prepa-
rations were stored in liquid nitrogen until further 
use. 
Lectins (Agglutinins) 
The following lectins were used: Anguilla anguilla 
(AAA), Bauhinia purpurea (BPA), Concanavalia en-
siformis (ConA), Dolichos biflorus (DBA), Erythrina 
cristagalli (ECA), Griffonia simplicifolia I (GSA-I), 
! 
Ill, 
11 (, 
52 
S. Winoto-Morbach. K. Ulrichs. B. J.Hering, G. Leyhausen and W. Muller-Ruchholtz 
Table 1 Binding pattern of lectins to crude bovine pancreatic islets. 
2 
OBA 
HPA 
PNA 
Groups of lectins 
3 4 5 
BPA 
RCA-I 
A: Lectins 
coupled 
toFITC 
B: Lectins 
coupled 
toMMS 
exo. 
endo. 
exo: 
endo. 
AAA 
UEA-I 
(+)/+ 
-/(+) 
ConA 
LCA 
LPA 
MPA 
+ 
-/(+) 
(+)/-
ECA 
GSA-I 
GSA-II 
SBA 
Succ.ConA 
Succ.WGA 
WFA 
WGA 
++ 
(+)/+ 
+/-
+++ 
++ 
+++ very strong; ++ strong; + medium; (+) weak; - no detectable binding; exo. exocrine; endo. endocrine. 
Table 2 Binding pattern of lectins to crude ,pig pancreatic islets. 
Groups of lectins 
2 3 4 5 
AAA BPA OBA LCA GSA-I 
ConA HPA Succ.ConA RCA-I 
ECA MPA UEA-I WFA 
GSA-II Succ.wGA 
LPA WGA 
PNA 
SBA 
A: Lectins exo. (+) + ++ +++ 
coupled 
toFITC endo. (+) 
B: Lectins exo: -/(+) (+) + ++ 
coupled n.d. 
toMMS endo. -/(+) 
+++ very strong; ++ strong; + medium; (+) weak; - no detectable binding; n.d. not done; exo. exocrine; endo. endocrine. 
Griffonia simplicifolia II (GSA-I1), Helix, pomatia 
(HPA) , Lens culinaris (LCA), Limulus polyhemus 
(LPA), Madura pomifera (MPA), Peanut = Arachis 
hypogaea (PNA), Ricinus communis I (RCA-I), Soy 
Bean = Glycine max (SBA), Succinyl Concanavalia 
ensiform is (Succ. ConA), Succinyl Wheat Germ = 
Triticum vulgaris (Succ. WGA), Ulex europaeus I 
(UEA-I), Wheat Germ = Triticum vulgaris (WGA), 
Wistaria floribunda (WFA). The Lectins were pur-
chased from Medac, Hamburg, Germany. 
Preparation of MMS and lectin coupling 
In brief, nontoxic albumin MMS of 800 nm size 
were prepared. Lectins were coupled to glutaralde-
hyde-activated MMS by incubating them for 2 h in 
phosphate-buffered saline (PBS). Binding of MMS 
to isolated pancreatic tissue and fluorescence studies 
performed on isolated pancreatic tissue were studied 
according to a recently published protocol (Winoto-
Morbach et al. 1989). 
ReSUlts 
19 different lectins were investigated in FITC- and 
MMS-binding studies. Each lectin that showed a 
strong and selective binding pattern and no loss of 
biological function after coupling to MMS was tested 
with various crude islet preparations from the species 
in question. The lectin-binding patterns for the 3 dif-
ferent species are summarized in Tables 1-3. 
Crude bovine islets (Table 1) 
Only two lectins, BPA and RCA-I, were suitable, 
according to their binding specificity to exocrine 
Table 
A: Le( 
COl 
to I 
B: Le( 
COL 
to' 
+++ ve 
tissue 
couph 
neithe 
and hI 
specie 
Crude 
Three 
bindin 
contra 
humar 
ocrine 
Crude 
The sa 
to rea' 
namel) 
tive bil 
Discu! 
Handp 
not apI 
needed 
transpl: 
undout 
1989;1 
so far 
purity 1 
islet gn 
Functic 
human 
in vitre 
tissue I 
genic it) 
F).Imn 
frozen I 
~d 
0-
ld 
a 
of 
~d 
es 
If-
.e, 
le 
I ~ 
Lectins for Electromagnetic Purification of Islets from Humans and Large Mammals 53 
Table 3 Binding pattern of lectins to crude dog pancreatic islets. 
2 
Groups of lectins 
3 4 5 
A: Lectins 
coupled 
to FITC 
B: Lectins 
coupled 
to MMS 
exo. 
endo. 
exo: 
endo. 
AAA 
PNA 
GSA-II 
ConA 
ECA 
LPA 
MPA 
+ 
+ 
DBA 
GSA-I 
UEA-I 
++ 
+ 
HPA 
LCA 
SBA 
Succ. ConA 
Succ. WGA 
WFA 
WGA 
++ 
+ 
+ 
(+)/-
BPA 
RCA-I 
+++ 
++ 
+++ very strong; ++ strong; + medium; (+) weak; - no detectable binding; exo. exocrine; endo. endocrine. 
tissue fragments. FITe-Iabeled and microsphere-
coupled lectins yielded similar results. Interestingly, 
neither UEA-I nor WFA, which were suitable in rat 
and human pancreatic tissue, were of any use in this 
species. 
Crude pig islets (Table 2) 
Three lectins, GSA-I, ReA-I and WFA, showed 
binding specificity to exocrine tissue fragments. In 
contrast to bovine tissue, but similar to results with 
human tissue, WFA reacted selectively with pig ex-
ocrine cells. 
Crude canine islets (Table 3) 
The same two lectins that had previously been found 
to react specifically with bovine exocrine tissue, 
namely BPA and ReA-I, showed the strongest selec-
tive binding to canine exocrine cells. 
Discussion 
Handpicking of islets, well established in rodents, is 
not applicable for the large quantity of purified islets 
needed, e.g., for human, bovine, pig, or canine islet 
transplantation. Density gradient centrifugation has 
undoubtedly been improved recently (Lake et al. 
1989; Ricordi et al. 1989; Warnock et al. 1989), but 
so far it does not provide the high degree of islet 
purity which is considered necessary for unimpaired 
islet graft function (Hering et al. 1989; Gray 1989). 
Functional immunogenicity studies with· crude 
human islet preparations compared to clean islets in 
in vitro tests have clearly shown that the exocrine 
tissue portion contributes greatly to graft immuno-
genicity (Ulrichs and MiUler-Ruchholtz, cf. chapter 
F). Immunohistological studies with human pancreas 
frozen tissue sections are in line with this functional 
data by showing large amounts of HLA-DR cells 
particularly within the exocrine tissue compartment. 
These are HLA-DR T lymphocytes, tissue macro-
phages otherwise known as "dendritic cells", vascu-
lar endothelial cells and duct epithelium (unpub-
lished observation). Islets clearly contain much fewer 
of these cells. Thus, the EMS technique may be the 
technique in demand to eliminate the contaminating 
exocrine tissue and provide pure islets for transplan-
tation. The feasibility of such an approach has been 
clearly shown in the rat system with well function-
ing, i.e., long-term surviving syngeneic rat islet 
grafts (MuUer-Ruchholtz et al. 1987). 
Preliminary EMS studies with crude human islets 
and the relevant MMS-coupled Wisteria floribunda 
lectin are similarly promising as to purity (>98%), 
yield (70%) and viability (>90%) of islets (Winoto-
Morbach et al. 1989; Winoto-Morbach et al. 1989), 
provided the islets in the preparation are well 
digested and thus without an exocrine rim. 
A different approach to achieve purity of canine is-
lets consists of the lysis of exocrine acinar cells by 
complement-activating, exocrine-specific mono-
clonal antibodies (Soon-Shiong, Heintz and Terasaki 
1988). The degree of purity has been reported to be 
in the range of 65-87%. These antibodies have re-
cently· been shown to be cross-reactive with human 
exocrine tissue (Soon-Shiong, Heintz and Terasaki 
1989). Similar to our approach they are presently 
coupled to dynabeads and used for electromagnetic 
purification of human islets (Soon-Shiong et aI., cf. 
chapter e). It will be interesting to compare the re-
sults of these two approaches in the near future. 
Monoclonal antibodies of our own production might 
be advantageous in view of the present high costs of 
lettins. 
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It is our present suggestion that optimal enzymatic 
islet digestion, followed by a pre-purification step, 
e.g., with density gradient centrifugation and a final 
purification step with the EMS technique, using 
either lectins or monoclonal antibodies to eliminate 
exocrine cells, may allow us to solve the problem of 
islet purity and quantity in the near future. 
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Abbreviations 
EMS = electromagnetic separation 
MMS = magnetic microspheres 
FITC = fluorescein isothiocyanate 
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Introduction 
The transplantation' of islets of Langerhans into 
humans or into large animal models is still hampered 
by the fact that the purification methods which are 
mainly based on gradient techniques show relatively 
low yields (Sutherland 1981). Furthermore small 
lymphnodes and vessels can not be. separated de-
finitely from the islets (Van Suylichem, Wolters and 
van Schilfgaarde 1989). 
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